European PRAC starts review of signal of thrombocytopenia with Pfizer/BioNTech, AstraZeneca and Moderna COVID-19 vaccines

Several cases of immune thrombocytopenia, an adverse event of special interest, were reported in the EudraVigilance database. The PRAC will carry out an in-depth review of all the available data for these three vaccines, to decide if a causal relationship is confirmed or not.

Source:

European Medicines Agency